Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
significant based » significant barrier (Expand Search), significant burden (Expand Search), significant causal (Expand Search)
significant cause » significant change (Expand Search), significant changes (Expand Search), significant gap (Expand Search)
Showing 1,501 - 1,520 results of 21,342 for search '(( significant decrease decrease ) OR ( ((significant based) OR (significant cause)) decrease ))', query time: 0.69s Refine Results
  1. 1501
    Lubrication Behavior of Fullerene-Coated Nanoparticles on Rough Surfaces

    Lubrication Behavior of Fullerene-Coated Nanoparticles on Rough Surfaces by Guangchao Han (1453198)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  2. 1502
    Lubrication Behavior of Fullerene-Coated Nanoparticles on Rough Surfaces

    Lubrication Behavior of Fullerene-Coated Nanoparticles on Rough Surfaces by Guangchao Han (1453198)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  3. 1503
    Lubrication Behavior of Fullerene-Coated Nanoparticles on Rough Surfaces

    Lubrication Behavior of Fullerene-Coated Nanoparticles on Rough Surfaces by Guangchao Han (1453198)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  4. 1504
    Lubrication Behavior of Fullerene-Coated Nanoparticles on Rough Surfaces

    Lubrication Behavior of Fullerene-Coated Nanoparticles on Rough Surfaces by Guangchao Han (1453198)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  5. 1505
    Lubrication Behavior of Fullerene-Coated Nanoparticles on Rough Surfaces

    Lubrication Behavior of Fullerene-Coated Nanoparticles on Rough Surfaces by Guangchao Han (1453198)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  6. 1506
    Lubrication Behavior of Fullerene-Coated Nanoparticles on Rough Surfaces

    Lubrication Behavior of Fullerene-Coated Nanoparticles on Rough Surfaces by Guangchao Han (1453198)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  7. 1507
    Lubrication Behavior of Fullerene-Coated Nanoparticles on Rough Surfaces

    Lubrication Behavior of Fullerene-Coated Nanoparticles on Rough Surfaces by Guangchao Han (1453198)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  8. 1508
    Lubrication Behavior of Fullerene-Coated Nanoparticles on Rough Surfaces

    Lubrication Behavior of Fullerene-Coated Nanoparticles on Rough Surfaces by Guangchao Han (1453198)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  9. 1509
    Lubrication Behavior of Fullerene-Coated Nanoparticles on Rough Surfaces

    Lubrication Behavior of Fullerene-Coated Nanoparticles on Rough Surfaces by Guangchao Han (1453198)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  10. 1510
    S2 File - Factors influencing effective decrease of controlled attenuation parameters in metabolic-associated steatotic liver disease: A multilevel linear regression analysis at Vajira Hospital

    S2 File - Factors influencing effective decrease of controlled attenuation parameters in metabolic-associated steatotic liver disease: A multilevel linear regression analysis at Va... by Sonsawan Sangprasert (22772538)

    Published 2025
    Save to List
    Saved in:
  11. 1511
    Main baseline characteristics of patients included in the study.

    Main baseline characteristics of patients included in the study. by Jie Liu (15128)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  12. 1512
    (A) Monthly drug costs of patients in the ESAs group and Roxadustat group.

    (A) Monthly drug costs of patients in the ESAs group and Roxadustat group. by Jie Liu (15128)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  13. 1513
    Study data.

    Study data. by Jie Liu (15128)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  14. 1514
    Mean hemoglobin levels of Roxadustat and ESAs groups over time.

    Mean hemoglobin levels of Roxadustat and ESAs groups over time. by Jie Liu (15128)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  15. 1515
    Morisky score for ESAs group and Roxadustat group.

    Morisky score for ESAs group and Roxadustat group. by Jie Liu (15128)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  16. 1516
    Patient flow diagram.

    Patient flow diagram. by Jie Liu (15128)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  17. 1517
    Mean total cholesterol levels over time in the roxadustat group (A) and ESAs group (B) according to the statins subgroup.

    Mean total cholesterol levels over time in the roxadustat group (A) and ESAs group (B) according to the statins subgroup. by Jie Liu (15128)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  18. 1518
    Summary of clinical outcomes after 9 months.

    Summary of clinical outcomes after 9 months. by Jie Liu (15128)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  19. 1519
    Approval by the research ethics committee.

    Approval by the research ethics committee. by Jie Liu (15128)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  20. 1520
    (A) Changes of left ventricular ejection fraction over time in Roxadustat and ESAs groups.

    (A) Changes of left ventricular ejection fraction over time in Roxadustat and ESAs groups. by Jie Liu (15128)

    Published 2025
    Subjects:
    Save to List
    Saved in:

Search Tools: